Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial

por Georgopoulos, Sotirios D., Papastergiou, Vasilios, Martinez-Gonzalez, Beatriz, Xirouchakis, Elias, Familias, Ioannis, Sgouras, Dionysis, Mentis, Andreas, Karatapanis, Stylianos
Publicado 2018